BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.92 +0.11 (+2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Debt Ratio (2023 - 2026)

Updated

BridgeBio Oncology Therapeutics' (BBOT) Debt Ratio was 0.00 for Q1 2026, up 284.8% from 0.00 a year earlier and up 43.9% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Debt Ratio (2023 - 2026) Analysis & Trends

Dating back to Q4 2023, BridgeBio Oncology Therapeutics' Debt Ratio record includes 7 quarters.

  • By year, Debt Ratio came in at 0.00 in FY2024 (-98.6%) and 0.21 in FY2023.
  • The Q1 2026 figure ranks as the highest quarterly Debt Ratio since Q4 2024.
  • Per Business Quant data, the three quarters before Q1 2026 came in at 0.00 (Q4 2025), 0.00 (Q3 2025) and 0.00 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BridgeBio Oncology Therapeutics 305.24 Mn -1.07 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Dec 31, 2023 0.21
API Access

BridgeBio Oncology Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BBOT&period=max&api_key=YOUR_API_KEY